{"mainPropery":{"diseaseId":7071,"diseaseName":"Mucopolysaccharidosis type IIIA","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7071/mucopolysaccharidosis-type-iiia","synonyms":["Mucopoly-saccharidosis type 3A","Sanfilippo syndrome A","Heparan sulfate sulfatase deficiency","MPS IIIA","MPS 3A","Heparan sulfamidase deficiency","MPS3A","MPSIIIA","Mucopolysaccharidosis type 3A","Sanfilippo syndrome type A"],"synonyms-with-source":[{"name":"Mucopoly-saccharidosis type 3A"},{"name":"Sanfilippo syndrome A"},{"name":"Heparan sulfate sulfatase deficiency"},{"name":"MPS IIIA"},{"name":"MPS 3A"},{"name":"Heparan sulfamidase deficiency","source":"OrphaData.Org"},{"name":"MPS3A","source":"OrphaData.Org"},{"name":"MPSIIIA","source":"OrphaData.Org"},{"name":"Mucopolysaccharidosis type 3A","source":"OrphaData.Org"},{"name":"Sanfilippo syndrome type A","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"252900"},{"identifierType":"ORPHANET","identifierId":"79269"},{"identifierType":"UMLS","identifierId":"C0086647"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":37,"resourceName":"Canadian Society for Mucopolysaccharide and Related Diseases Inc. (Canadian MPS Society)","abbreviation":"","address1":"#218-2055 Commercial Drive ","address2":"Vancouver, BC V5N OC7","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"604-924-5130","tty":"","tollFree":"800-667-1846","fax":"604-924-5131","email":"info@mpssociety.ca","url":"http://www.mpssociety.ca","freeText":""},{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":209,"resourceName":"National MPS Society","abbreviation":"","address1":"P.O. Box 14686 ","address2":"","address3":"","address4":"","address5":"","city":"Durham","state":"NC","zip":"27709-4686","country":"United States","phone":"+1-919-806-0101","tty":"","tollFree":"1-877-MPS-1001 (1-877-677-1001)","fax":"+1-919-806-2055","email":"info@mpssociety.org","url":"https://mpssociety.org/","freeText":""},{"resourceID":210,"resourceName":"Society for Mucopolysaccharide (MPS) Diseases","abbreviation":"","address1":"MPS House Repton Place White Lion Road","address2":"Amersham Buckinghamshire","address3":"HP7 9LP","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"(+44) 0345 389 9901 ","tty":"","tollFree":"","fax":"","email":"mps@mpssociety.co.uk","url":"http://www.mpssociety.co.uk","freeText":""},{"resourceID":318,"resourceName":"Hide and Seek Foundation for Lysosomal Storage Disease Research","abbreviation":"","address1":"6475 East Pacific Coast Highway","address2":"Suite 466","address3":"","address4":"","address5":"","city":"Long Beach","state":"CA","zip":"90803 ","country":"United States","phone":"","tty":"","tollFree":"(844) 762-7672","fax":"","email":"info@hideandseek.org","url":"https://hideandseek.org","freeText":""},{"resourceID":763,"resourceName":"Team Sanfilippo Foundation","abbreviation":"","address1":"PO Box 1152","address2":"","address3":"","address4":"","address5":"","city":"Ronkonkoma","state":"NY","zip":"11779","country":"United States","phone":"518-879-6571 ","tty":"","tollFree":"","fax":"","email":"http://teamsanfilippo.org/contact-us","url":"http://www.teamsanfilippo.org/","freeText":""},{"resourceID":3755,"resourceName":"Cure Sanfilippo Foundation","abbreviation":"","address1":"PO Box 6901","address2":"","address3":"","address4":"","address5":"","city":"Columbia","state":"SC","zip":"29260","country":"","phone":"803-413-0595","tty":"","tollFree":"","fax":"","email":"Contact@CureSanfilippoFoundation.org","url":"https://curesanfilippofoundation.org/","freeText":""},{"resourceID":4310,"resourceName":"Sanfilippo Children's Foundation","abbreviation":"","address1":"PO Box 475","address2":"Freshwater NSW 2096","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Australia","phone":"1800 664 878 ","tty":"","tollFree":"","fax":"","email":"","url":"https://www.sanfilippo.org.au/","freeText":"Contact form: https://www.sanfilippo.org.au/about-us/contact-us"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/252900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=252900' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Mucopolysaccharidosis type IIIA. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Mucopolysaccharidosis+type+IIIA%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Mucopolysaccharidosis type IIIA. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/mucopolysaccharidosis-type-iii' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Mucopolysaccharidosis type IIIA. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":267,"resourceId":1104,"resourceName":"American Society of Gene & Cell Therapy -Disease treatment","descriptionText":"The <a href='https://www.asgct.org/education' target='_blank'>American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of genetic diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/sanfilippo-syndrome' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":869,"resourceId":1575,"resourceName":"RDCRN - Lysosomal Disease Network","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/ldn' target='_blank'>Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br />","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0086647/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/290/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001210.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/mucopolysaccharidoses/detail_mucopolysaccharidoses.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/948540-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022495' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79269' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:12801' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3297,"questionText":"What is mucopolysaccharidosis type IIIA?","answerText":"<strong>Mucopolysaccharidosis type IIIA (MPS IIIA)</strong> is a severe, progressive disorder that affects the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002311.htm#visualContent\" target=\"_blank\">central nervous system</a>.[7379] In people with MPS IIIA, the body cannot break down a large sugar molecule called heparin sulfate.[950][951] Signs and symptoms usually begin in early childhood and include severe neurological symptoms such as progressive dementia, aggressive behavior, hyperactivity, seizures, deafness, loss of vision, and an inability to sleep for more than a few hours at a time.[950][7379] MPS IIIA is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SGSH\" target=\"_blank\">SGSH</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[7379] There is currently no specific treatment for MPS IIIA; affected people usually do not survive past the second decade of life.[7380]","dateModified":"2015-07-21T00:00:00"},"basicQuestions":[{"questionId":7489,"questionText":"Is carrier testing available for relatives of people with mucopolysaccharidosis type IIIA?","answerText":"While a diagnosis of mucopolysaccharidosis type IIIA (MPS IIIA) is typically confirmed by a biochemical genetic test called an enzyme assay, carrier testing with an enzyme assay is generally unreliable due to a wide variation in enzyme concentrations. If molecular genetic testing (which looks at the DNA) has been done on the affected family member and the mutation(s) have been identified, molecular genetic testing can then also be used to identify carriers among siblings or other relatives.[7382]<br />\r\n<br />\r\nIf a carrier of MPS IIIA is concerned about having an affected child, his/her partner can be screened for the most common mutations known to cause the condition.[7382] If no mutation is found in the partner, that person's risk to be a carrier would decrease significantly but would not be eliminated.<br />\r\n<br />\r\nPeople interested in obtaining more specific information about genetic testing and/or carrier screening for MPS IIIA should speak with a genetics professional.","dateModified":"2014-05-06T10:26:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7382,"authors":"Emil Kakkis and Robert Wynn","articleTitle":"Mucopolysaccharidoses: Clinical features and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"May, 2014","volume":"","pages":"","url":"","dateAccessed":"2014-05-07T00:00:00","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":9131,"questionText":"How might mucopolysaccharidosis type IIIA be treated?","answerText":"Unfortunately, there is currently no cure or standard treatment for people with mucopolysaccharidosis type IIIA (MPS IIIA). Affected people and their families should consult with a medical genetics team for information about the diagnosis, counseling, up-to-date treatment options, and referrals to support groups and organizations. Treatment requires ongoing care with trained pediatric specialists in various medical fields. A consultation with a developmental pediatrician is especially helpful in addressing behavioral concerns and to assist parents and caregivers in establishing a sleep routine.<br />\r\n<br />\r\nCurrently, drug therapy is not part of the standard of care for MPS IIIA. Medications are used to relieve symptoms (such as anticonvulsants for seizures) and improve quality of life. Sedatives and <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/natural/940.html\" target=\"_blank\">melatonin</a> have been used to improve the quality of sleep along with establishing a bedtime routine. Specific therapies such as <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm\" target=\"_blank\">bone marrow transplantation</a> and enzyme replacement therapy (ERT) are currently not options for patients with MPS IIIA. <a href=\"http://www.merckmanuals.com/home/immune-disorders/transplantation/stem-cell-transplantation\" target=\"_blank\">Hematopoietic stem cell transplantation</a> has shown mixed results and an unclear neurocognitive benefit. <a href=\"http://www.merriam-webster.com/medlineplus/recombinant\" target=\"_blank\">Recombinant</a> enzymes for the deficiencies in MPS III are available, but trials in ERT have not been favorable in improving prognosis because the enzymes are not able to enter the central nervous system.[9350] Changes to the diet do not prevent disease progression, but limiting milk, sugar, and dairy products has helped some people who have excessive mucus.[9349]","dateModified":"2015-07-21T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9349,"authors":"","articleTitle":"Mucopolysaccharidoses Fact Sheet","bookWebsiteJournalTitle":"NINDS","date":"June 30, 2015","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/mucopolysaccharidoses/detail_mucopolysaccharidoses.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9350,"authors":"Germaine L Defendi","articleTitle":"Genetics of Mucopolysaccharidosis Type III","bookWebsiteJournalTitle":"Medscape","date":"March 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/948540-treatment","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":3807,"relatedDiseaseName":"Mucopolysaccharidosis type III","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":52505,"abbreviatedInquiry":"My daughter was diagnosed with MPS 3A. How is this condition managed and are there possibilities of a cure?","caseQuestions":[{"questionId":9131,"questionText":"How might mucopolysaccharidosis type IIIA be treated?","answerText":"Unfortunately, there is currently no cure or standard treatment for people with mucopolysaccharidosis type IIIA (MPS IIIA). Affected people and their families should consult with a medical genetics team for information about the diagnosis, counseling, up-to-date treatment options, and referrals to support groups and organizations. Treatment requires ongoing care with trained pediatric specialists in various medical fields. A consultation with a developmental pediatrician is especially helpful in addressing behavioral concerns and to assist parents and caregivers in establishing a sleep routine.<br />\r\n<br />\r\nCurrently, drug therapy is not part of the standard of care for MPS IIIA. Medications are used to relieve symptoms (such as anticonvulsants for seizures) and improve quality of life. Sedatives and <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/natural/940.html\" target=\"_blank\">melatonin</a> have been used to improve the quality of sleep along with establishing a bedtime routine. Specific therapies such as <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm\" target=\"_blank\">bone marrow transplantation</a> and enzyme replacement therapy (ERT) are currently not options for patients with MPS IIIA. <a href=\"http://www.merckmanuals.com/home/immune-disorders/transplantation/stem-cell-transplantation\" target=\"_blank\">Hematopoietic stem cell transplantation</a> has shown mixed results and an unclear neurocognitive benefit. <a href=\"http://www.merriam-webster.com/medlineplus/recombinant\" target=\"_blank\">Recombinant</a> enzymes for the deficiencies in MPS III are available, but trials in ERT have not been favorable in improving prognosis because the enzymes are not able to enter the central nervous system.[9350] Changes to the diet do not prevent disease progression, but limiting milk, sugar, and dairy products has helped some people who have excessive mucus.[9349]","dateModified":"2015-07-21T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9349,"authors":"","articleTitle":"Mucopolysaccharidoses Fact Sheet","bookWebsiteJournalTitle":"NINDS","date":"June 30, 2015","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/mucopolysaccharidoses/detail_mucopolysaccharidoses.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9350,"authors":"Germaine L Defendi","articleTitle":"Genetics of Mucopolysaccharidosis Type III","bookWebsiteJournalTitle":"Medscape","date":"March 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/948540-treatment","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9132,"questionText":"Might there be a treatment or cure for mucopolysaccharidosis type IIIA in the near future?","answerText":"Studies investigating potential treatments for mucopolysaccharidosis type IIIA (MPS IIIA) are ongoing. Presently, the use of enzyme injections directly into the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002311.htm#visualContent\" target=\"_blank\">central nervous system</a>&nbsp;are being investigated, with clinical trials underway.[9350]<br />\r\n<br />\r\nResearch has shown that viral-delivered <a href=\"http://ghr.nlm.nih.gov/handbook/therapy/genetherapy\" target=\"_blank\">gene therapy</a> in animal models can stop the buildup of storage materials in brain cells and improve learning and memory. Researchers are planning additional studies to understand how gene therapy prompts recovery of mental function in these animal models. However, it may be years before such treatment is available to humans.[9349]","dateModified":"2015-07-21T00:00:00","references":[{"referenceId":9349,"authors":"","articleTitle":"Mucopolysaccharidoses Fact Sheet","bookWebsiteJournalTitle":"NINDS","date":"June 30, 2015","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/mucopolysaccharidoses/detail_mucopolysaccharidoses.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9350,"authors":"Germaine L Defendi","articleTitle":"Genetics of Mucopolysaccharidosis Type III","bookWebsiteJournalTitle":"Medscape","date":"March 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/948540-treatment","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9135,"questionText":"Where can I view information about clinical trials for the treatment of mucopolysaccharidosis type IIIA?","answerText":"The U.S. National Institutes of Health (NIH), through the National Library of Medicine, developed <a href=\"https://www.clinicaltrials.gov/\" target=\"_blank\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. To find trials involving mucopolysaccharidosis type IIIA, click on the link below. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study&rsquo;s contact information to learn more. Check this site often for regular updates.<br />\r\n<br />\r\n<a href=\"https://www.clinicaltrials.gov/ct2/results?term=mucopolysaccharidosis+III+A&amp;Search=Search\" target=\"_blank\">https://www.clinicaltrials.gov/ct2/results?term=mucopolysaccharidosis+III+A&amp;Search=Search</a><br />\r\n<br />\r\nYou can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the NIH. We recommend calling 1-800-411-1222 to speak with a specialist who can help you determine if you are eligible for any clinical trials. If you are located outside the United States, and would like to be contacted via telephone, you will need to contact PRPL and provide your telephone number in full, including area code and international dialing prefix.&nbsp;<br />\r\n<br />\r\nPatient Recruitment and Public Liaison Office&nbsp;<br />\r\nNIH Clinical Center&nbsp;<br />\r\nBethesda, Maryland 20892-2655&nbsp;<br />\r\nToll-free: 1-800-411-1222&nbsp;<br />\r\nFax: 301-480-9793&nbsp;<br />\r\nE-mail: <a href=\"mailto:prpl@mail.cc.nih.gov\" target=\"_blank\">prpl@mail.cc.nih.gov</a>&nbsp;<br />\r\nWeb site: <a href=\"http://clinicalcenter.nih.gov\" target=\"_blank\">http://clinicalcenter.nih.gov</a>&nbsp;<br />\r\n<br />\r\nYou can find information about participating in a clinical trial as well as learn about resources for travel and lodging assistance, through the <a href=\"https://rarediseases.info.nih.gov/research/10/get-involved-in-research\" target=\"_blank\">Get Involved in Research</a> section of our Web site.","dateModified":"2015-07-21T12:19:00","references":[]}]},{"caseId":45350,"abbreviatedInquiry":"My family is known to carry the genes for Sanfilippo A or MPS IIIA. Is there a test that I can request when I conceive to know if my child will have the disease? I understand to have myself/my husband tested it is very pricey. What options do we have? How early can we test a fetus? My cousin had the disease and any help would be greatly appreciated.","caseQuestions":[{"questionId":7490,"questionText":"Is prenatal diagnosis available for mucopolysaccharidosis type IIIA?","answerText":"Prenatal diagnosis is available for couples with an increased risk to have a baby with mucopolysaccharidosis type IIIA (MPS IIIA). The most commonly used method is a direct enzyme test on material obtained by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003406.htm\" target=\"_blank\">chorionic villus sampling (CVS)</a> at 10-12 weeks gestation. Enzyme activity can also be measured in cultured cells obtained by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003921.htm\" target=\"_blank\">amniocentesis</a>, but the method involving CVS avoids the need for tissue culture and provides results earlier and more quickly.[7382]<br />\r\n<br />\r\nFetal enzyme activity can also be measured in dried fetal blood spots; however, this is typically reserved for cases of hydrops fetalis, a common feature of MPS type VII.[7382]<br />\r\n<br />\r\nPeople interested in learning more about prenatal diagnosis for MPS IIIA should speak with a genetics professional.","dateModified":"2014-05-06T13:52:00","references":[{"referenceId":7382,"authors":"Emil Kakkis and Robert Wynn","articleTitle":"Mucopolysaccharidoses: Clinical features and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"May, 2014","volume":"","pages":"","url":"","dateAccessed":"2014-05-07T00:00:00","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":7489,"questionText":"Is carrier testing available for relatives of people with mucopolysaccharidosis type IIIA?","answerText":"While a diagnosis of mucopolysaccharidosis type IIIA (MPS IIIA) is typically confirmed by a biochemical genetic test called an enzyme assay, carrier testing with an enzyme assay is generally unreliable due to a wide variation in enzyme concentrations. If molecular genetic testing (which looks at the DNA) has been done on the affected family member and the mutation(s) have been identified, molecular genetic testing can then also be used to identify carriers among siblings or other relatives.[7382]<br />\r\n<br />\r\nIf a carrier of MPS IIIA is concerned about having an affected child, his/her partner can be screened for the most common mutations known to cause the condition.[7382] If no mutation is found in the partner, that person's risk to be a carrier would decrease significantly but would not be eliminated.<br />\r\n<br />\r\nPeople interested in obtaining more specific information about genetic testing and/or carrier screening for MPS IIIA should speak with a genetics professional.","dateModified":"2014-05-06T10:26:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7382,"authors":"Emil Kakkis and Robert Wynn","articleTitle":"Mucopolysaccharidoses: Clinical features and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"May, 2014","volume":"","pages":"","url":"","dateAccessed":"2014-05-07T00:00:00","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":7491,"questionText":"What testing options are available for people with a family history of mucopolysaccharidosis type IIIA?","answerText":"The specific testing options for people with a family history of MPS IIIA depend on several factors which may include the specific relationship to the affected person; whether the affected person's mutation(s) are known; and whether other people in the family have been tested (and their results).&nbsp;A genetic counselor can help people with questions determine what their genetic risks are, whether testing is appropriate, who might benefit from testing, and what the testing options in each case are.<br />\r\n<br />\r\nIn many cases, health insurance will cover the costs of genetic testing when it is recommended by a physician or other health care provider. However, insurance companies have different policies about which tests are covered. Some insurers have specific requirements for the reason (indication) for testing to qualify for coverage. People with questions about coverage for a specific genetic test should check with their insurance company.[7383]","dateModified":"2014-05-07T11:53:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7383,"authors":"","articleTitle":"Your Genetic Health: Patient Information","bookWebsiteJournalTitle":"National Society of Genetic Counselors","date":"","volume":"","pages":"","url":"http://nsgc.org/p/cm/ld/fid=144","dateAccessed":"2014-05-07T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8996,"phenoTypeName":"Asymmetric septal hypertrophy","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":9878,"phenoTypeName":"Coarse facial features","percentRanges":"-"},{"phenoTypeId":8077,"phenoTypeName":"Coarse hair","percentRanges":"-"},{"phenoTypeId":9836,"phenoTypeName":"Dense calvaria","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":10270,"phenoTypeName":"Dysostosis multiplex","percentRanges":"-"},{"phenoTypeId":4078,"phenoTypeName":"Growth abnormality","percentRanges":"-"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","percentRanges":"-"},{"phenoTypeId":13754,"phenoTypeName":"Heparan sulfate excretion in urine","percentRanges":"-"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","percentRanges":"-"},{"phenoTypeId":8284,"phenoTypeName":"Hirsutism","percentRanges":"-"},{"phenoTypeId":14144,"phenoTypeName":"Hyperactivity","percentRanges":"-"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","percentRanges":"-"},{"phenoTypeId":5683,"phenoTypeName":"Joint stiffness","percentRanges":"-"},{"phenoTypeId":10995,"phenoTypeName":"Ovoid thoracolumbar vertebrae","percentRanges":"-"},{"phenoTypeId":7888,"phenoTypeName":"Recurrent upper respiratory tract infections","percentRanges":"-"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","percentRanges":"-"},{"phenoTypeId":11439,"phenoTypeName":"Sleep disturbance","percentRanges":"-"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","percentRanges":"-"},{"phenoTypeId":10139,"phenoTypeName":"Synophrys","percentRanges":"-"},{"phenoTypeId":10230,"phenoTypeName":"Thickened ribs","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Mucopolysaccharidosis_type_IIIA"}